Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Sanofi buys Vigil Neuroscience for $470m

Digest more
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
Key Takeaways Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by Sanofi.French pharmaceutical giant Sanofi agreed to pay $8.00 per share in cash at closing,

Continue reading

 · 2d · on MSN
 · 2d · on MSN
Sanofi to buy Vigil Neuroscience in $470M deal (update)
 · 2d
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
PharmTech22h
Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
Fierce Biotech2d
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...
3h
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates The Merger Of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. Attorney Advertising. (C) 2025 Monteverde & Associates PC ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy